C-type natriuretic peptide is a potent activator of guanylate cyclase in endothelial cells from brain microvessels

• Published in: Biochemical and biophysical research communications Vol. 183; no. 2; p. 640
• Main Authors: Vigne, P, Frelin, C
• Format: Journal Article
• Language: English
• Published: United States 16-03-1992
• Subjects: Animals; Atrial Natriuretic Factor - pharmacology; Brain - enzymology; Dose-Response Relationship, Drug; Endothelium, Vascular - enzymology; Enzyme Activation; Guanylate Cyclase - drug effects; Guanylate Cyclase - metabolism; Microcirculation - enzymology; Natriuretic Peptide, Brain; Natriuretic Peptide, C-Type; Nerve Tissue Proteins - pharmacology; Rats
• ISSN: 0006-291X
• DOI: 10.1016/0006-291x(92)90530-x

An exposure of endothelial cells from rat brain microvessels to C-type natriuretic peptide (CNP) resulted in a rapid and large increase in cGMP formation. The action of CNP did not require inhibitors of phosphodiesterases to be observed and occurred at nanomolar concentrations. Other natriuretic peptides (ANP and BNP) also stimulated cGMP formation in endothelial cells from brain microvessels but with a potency that was at least 100 times less than that of CNP. In contrast, endothelial cells from the aorta showed large cGMP responses to low concentrations of ANP and BNP but were unresponsive to CNP up to concentrations as large as 100 nM. It is concluded that endothelial cells from brain microvessels and from aorta express different receptors subtypes for natriuretic peptides. Endothelial cells from brain microvessels express CNP specific ANPB receptors; aortic endothelial cells express ANP (and BNP) specific ANPA receptors. CNP may play an important role in the regulation of water and electrolyte movements across the blood brain barrier.